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ABSTRACT 
 
Introduction 
Social capital is seen as “the features of social organization that include civic 
participation, norms of reciprocity, and trust in others that facilitate cooperation for 
mutual benefit”. There has been a growing interest in social capital and HIV treatment 
outcomes. However, the impact of social capital on HIV treatment outcomes remains 
relatively undefined. The aim of this study was to establish whether social capital is 
associated with HIV treatment outcomes, particularly ART adherence and virological 
failure, in HIV patients on ART in South Africa.  
 
Materials and Methods 
This was a cross-sectional analysis of secondary data from a cohort study that 
investigated how patient outcomes were linked to clinical characteristics. The cohort 
study was conducted at private and non-governmental (NGO) clinics that were supported 
by the Aurum Institute for antiretroviral therapy implementation. Participants (n=943) 
identified by clinic staff as being suitable for inclusion in the study (n=943) were 
interviewed as they exited from their clinic visit, after giving written informed consent. 
Questions regarding HIV adherence and perceptions around HIV and health were 
important determinants of adherence in this population. Participant information was 
linked with the database. Data analyses included descriptive statistic and logistic 
regression. Stata computer software version 12 was used for the analysis. 
 
Results 
Being employed and increasing age were found to be associated with social capital 
(p=0.01 and p=0.07, respectively). The association between social capital and visit non-
adherence was not statistically significant. Social capital was, however, significantly 
associated with unsuppressed viral load at 12 months (OR=0.47; 95% CI=0.25-0.88) and 
with treatment failure at 12 months (OR=0.59; 95% CI=0.37-0.97) in the univariable 
analysis. 
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After controlling for age, marital status, education and occupation, higher social capital 
was still significantly associated with a lower risk of unsuppressed viral load at 12 
months (OR=0.48; 95% CI=0.24-0.96) and lower risk of treatment failure at 12 months 
(OR=0.52; 95% CI=0.32-0.88).  
 
Conclusion and Recommendations 
This study is the first to investigate the association between social capital and HIV 
treatment outcomes. We found that patients in the study who were older (>40 years old) 
and who were employed, had higher social capital. Further research needs to be 
conducted to determine the relationship between social capital and HIV treatment 
outcomes. Public health policy-makers should adopt policies that are focused on 
individual younger than 18 years. Promoting youth organizations and family support is 
crucial to reinforce social capital in young adults. It is equally important policy to target 
unemployed people. Proactive decisions need to be made for the development of social 
networks that can facilitate and encourage collective and mutual actions and cooperation. 
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DEFINITIONS OF TERMS 
 
Antiretroviral treatment (ART) – a therapy used in treating HIV infection, usually 
given as a combination of three drugs: first line usually made up of two nucleoside 
reverse transcriptase inhibitors and one nucleoside reverse transcriptase (Thanker and 
Snow, 2003).  
 
Social capital - the features of social organisation, such as trust, norms and networks that 
can improve the efficiency of society by facilitating coordinated action (Putnam, 1995). 
 
Visit adherence - 4 to 6 visits over the first 12 months after start of ART, in this study 
population. 
 
Treatment retention – a patient still on treatment twelve (12) months after start of ART. 
 
Virological suppression – HIV RNA viral load ≤400 copies/ml at twelve (12) months 
after start of ART. 
 
Virological failure – a virological rebound after complete suppression of the virus. 
 
Virological rebound - the first viral load >400 copies/ml after achieving initial virologic 
suppression (<400 copies/ml). 
 
1 
 
1 INTRODUCTION 
 
1.1 Background 
 
Human Immunodeficiency Virus (HIV) is a virus that gradually attacks the human 
immune system cells. The advanced form of HIV disease is referred to as Acquired 
Immune Deficiency Syndrome (AIDS). The concept has played into the health outcomes 
among People Living with HIV/ AIDS. This group of people is considered globally to be 
a marginalised population.  
 
UNAIDS (2011) published HIV/AIDS statistics for the period 2009 – 2011, showing the 
effects of the epidemic in sub-Saharan Africa.  The same report, citing 2010 data, 
estimated that 68% of all people living with HIV resided in sub-Saharan Africa. The 
report cited that AIDS- related deaths in the region during the same year were 
approximately 1.2 million, and that 1.9 million people became infected with HIV.  In 
addition, it was estimated that, in 2010, 22.9 million people in total were living with HIV 
in sub-Saharan Africa with an estimated 5.6 million people in South Africa (the highest 
number of people in any country). It was estimated that 310 000 South Africans died of 
AIDS-related causes,  reflecting the huge number of lives that the country has lost to 
AIDS over the last three decades (HIV/AIDS, 2012).  
 
HIV treatment programmes have measurabley reduced morbidity and mortality. UNAIDS 
(2012) reported that, in 2011, ART had expanded to cover an additional 650 000 patients 
in South Africa. South Africa has made remarkable progress in providing access to 
antiretroviral treatment (ART) and the country is currently implementing the largest ART 
programme in the world (WHO and UNICEF, 2011).  
 
The South Africa 2010 country progress report had as its goal to provide an appropriate 
package of ART care and support services to 80% of people living with HIV and their 
families (Department of Health, 2010). The South African ARV programme reached 
45.1% of children zero to fourteen years old in need of ART and 28.9% of  young adults 
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(15-49 years) and 42.7% of old adult (>50 years) (Simbayi et al., 2014). A key challenge 
is treatment retention.  
 
Social capital includes several aspects that are used differently across disciplines. Social 
capital is a concept that has been widely studied and discussed in public health over the 
past decade (Webel et al., 2012). In health outcomes research, social capital is justified to 
aid the understanding of behavioural and structural risks to particular diseases, variation 
in health outcomes and coping with chronic illnesses. Social capital in health research is 
perceived differently in the contexts of social networks and social cohesion Social 
networks consider both personal- and group-based social networks as well as access to 
resources within such networks. More specifically, social capital is seen as “the features 
of social organization that include civic participation, norms of reciprocity, and trust in 
others that facilitate cooperation for mutual benefit” (Kawachi et al., 1997). Social 
relations are influenced by external events. In the case of HIV, the greatest challenge may 
be that of stigma: social capital may reduce or increase both the perception and 
experience of stigma, thereby influencing HIV treatment adherence. The main pathways 
through which social networking might influence health outcomes include social support, 
social influence, social engagement, person-to-person contact, and access to material 
resources.  
 
The Australian Depart of Health (Cullen and Whiteford, 2001), citing the World Bank 
(2001) definition of social capital, explained that, although there are varying definitions 
of social capital and what it encompasses, most social capital conceptualisations 
described the process as networks of people deriving benefit from common interaction 
with each other. Putnam et al. (1993) defined social capital as the “features of social 
organization, such as trust, norms and networks, which can improve the efficiency of 
society by facilitating coordinated action”.  
 
Studies have postulated that social support can influence health outcomes through 
provision or exchange of emotional, informational or instrumental resources in response 
to a perceived need or through influence on cognitions, emotions, behaviours and 
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biological responses that enhance health. There is a growing belief that social captital is 
vital in promoting HIV treatment retention. Pronyk et al. (2008) postulated that, in some 
settings in South Africa, high levels of social capital and community cohesion could 
provide protection and facilitate a more effective collective response to the HIV epidemic 
(Pronyk et al., 2008b) . Cene et al. (2011) provided strategies for strenghtening treatment 
retention tailored to available community resources/support systems with the potential to 
improve patient visit adherence and HIV treatment outcomes in South Africa (Cene et al., 
2011). Their strategies were based on combating HIV-related stigma through various 
levels of interactions between individuals and their communities. Essentially, what drove 
the strategies included four themes based on interpersonal processes, the community 
structure environment, social disorder and civic engagements.   
 
Several other reports have discussed the negative impact of social capital and HIV/AIDS 
on communities, including (i) the lack of privacy; (ii) the lack of anonymity in rural 
communities that has an impact on individuals’ decisions to submit to testing for HIV 
infection; and (iii) refusal to attend HIV/AIDS prevention and education programmes, if 
they do exist. The presence of facilities and programmes in communities that target 
treatment of HIV/AIDS patients can be perceived as being sufficient prevention and 
support. There is a need for an evaluation of any preventative and support programme to 
determine whether people use these services. Reimer (2002) provided an example of the 
distinction between the presence of facilities and support programmes and the use of 
social capital. These distinctions were of particular importance when considering their 
usefulness in terms of the services they provide (Reimer, 2002). Campbell, et al. (2002) 
argued that frequent church attendance shows positive social capital but stopped short of 
considering certain religious values as a barrier that provided some strong resistance to 
preventive measures. These religious values restricted the teaching of sexual education, 
the use of condom as a preventive measure, and homosexuality (Campbell et al., 2002). 
(Carwein et al., 1993) and (Smith et al., 1990) went on to further discuss how people 
living with HIV were seen as been immoral and so deserved to be  infected.  
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South Africa’s governmental ART programme does not have a central patient monitoring 
and data management system. A WHO (2004) report on decentralisation of health 
services, indicated that central patient monitoring and data management systems were 
widely accepted in the policy agenda of most countries in Sub-Saharan Africa. The 
programme to decentralise health services, including ART programmes, in South Africa 
did not lead to any short-term improvement in service output, in spite of the present 
levels of resources. This view is supported by findings by Hanson (2000) on the 
decentralisation of the health sector. While decentralisation has allowed for the 
strengthening of decision-making at local levels, it has also become an important element 
in scaling up ART. Decentralisation of ART programmes can create space for innovation 
and community participation, making it conducive to the successful implementation of 
ART programmes. However, due to these challenges, information on social capital, in 
general, is difficult to collect in a systematic way.  For these reasons, most literature 
[Campbell et al. (2002, 2008); Pronyk et al. (2008); Wouters et al. (2009); Cene et al. 
(2011); Webel et al. (2012)] on HIV/AIDS in South Africa does not include information 
about the impact of social capital on HIV treatment outcomes. However, by fully 
understanding the association between social capital and HIV, we should be able to 
identify which patients to focus more efforts on in terms of visit adherence, virological 
suppression and treatment failure.  These efforts must be matched by effective support 
groups which could be helpful in populations with low social capital. 
 
There are several research reports on social capital and HIV in South Africa . They 
include work by  Pronyk et al. (2008a,  2008b), Campbell et al. (2002), and Wouters et al. 
(2009).   Pronyk et al. (2008) looked at aspects of HIV-related psycho-socio attributes 
linked to social capital . They assessed whether  social capital can be intentionly 
generated by examining the way in which economic and social gains were able to 
enhance individual participation in social groups (Pronyk et al., 2008a).  Wouters et al. 
(2009) discussed  the association between bridging and bonding social capital in relation 
to  the  impact they had on public disclosure by people infected by HIV (Wouters et al., 
2009). They showed that bonding social capital had a positive influence on public 
disclosure. Campbell et al. (2008) described the chances of being  infected or not infected 
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by HIV through group membership of funding schemes. They varied across age and 
gender. Young men and women belonging to a group were more likely to engage in safe 
sexual behavior compared to those who did not belong to a group (Campbell et al., 2002). 
None of these studies measured the association of social capital and HIV outcomes, 
however, and all suggested the need for further research in this area. 
 
 
1.2 Justification for the study 
 
The need to explore the association between social capital and HIV treatment outcomes 
has been suggested in several reports [Campbell et al. (2002,2008); Pronyk et al. (2008); 
Wouters et al. (2009); Cene et al. (2011); Webel, et al (2012)]. Their studies   focused on 
the association between people living with HIV/AIDS and social engagements.  
 
The current study, which aimed to determine the association between social capital and 
HIV/AIDS treatment outcomes in South Africa,  follows from the need suggested by 
other researchers to further investigate the influences on HIV/AIDS treatment outcomes 
with regard to patients involvements in social engagements. Essentially, this work allows 
us to determine to what extend patients’ social engagements influence their 
behaviour/attitudes towards treatment regimens, with subsequent implications for 
treatment outcomes.  
 
Knowledge on whether social capital influences HIV/AIDS treatment outcomes would 
assist in the design of ART programmes.  Furthermore, the assumptions are that the 
research findings from the associations between social capital and HIV/AIDS treatment 
outcomes could serve to contribute to current and future South African public health 
policies.  
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1.3 Literature review 
 
Very few studies have looked at the association between social capital and HIV outcomes 
(adherence, virological suppression, and immune restoration) in South Africa. There are, 
however, studies in other countries that have shown associations between social factors 
and HIV risk/HIV adherence. 
 
Studies conducted in developed countries on social capital and HIV/AIDS treatment 
outcomes include those in the United States of America (Campbell et al., 2002; Friedman 
et al., 2007; Kawachi et al., 1997; Webel et al., 2012; Coleman et al., 1988) and Canada 
(Webel et al., 2012). However, there have been more studies conducted on the 
association between social capital and HIV/AIDS treatment outcomes in developing 
countries.  Studies in Africa looking at social capital include a multicentre study  from 
sites in  Botswana, Burkina Faso, Cameroon, the Democratic Republic of Congo ,Ivory 
Coast, Malawi, Mali, Namibia, Nigeria, Rwanda, Senegal, South Africa, Tanzania and 
Uganda (Mills et al., 2006), and individual sites in Zimbabwe (Gregson et al., 2011), 
Tanzania (Frumence et al., 2010) , Uganda (Agardh et al., 2010) and South Africa 
(Pronyk et al., 2008a, Pronyk et al., 2008b). 
 
Only four of these studies looked at social aspects that might influence HIV outcomes. In 
a meta-analysis of studies conducted in sub-Saharan Africa and North America, high 
levels ART adherence were found in patients where family members and friends had a 
significant influence on patients by providing direct observed therapy that helped in 
improving and maintaining high levels of adherence to ART (Mills et al., 2006). They 
also measured adherence success associated with social capital in sub-Saharan Africa 
(Uganda, Nigeria, Senegal, Cameroon, South Africa, Botswana, Burkina Faso, Mali, 
Malawi, Ivory Coast, Tanzania, Democratic Republic of Congo, and Rwanda) and North 
America (Canada and United States of America).  Social capital was described as 
explaining adherence successes and the threat of stigma. The preservation of social 
capital was observed to be important for adherence successes and the authors described 
the influences of social structure, infrastructure, culture, individual experience and 
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behaviour on HIV outcomes (Ware et al., 2009). In North America, China and Namibia, 
Webel et al. (2012) looked at the association between social capital and HIV outcomes 
amongst people living with HIV/AIDS. They found strong evidence to suggest that social 
capital can be used to influence health outcomes.  They found that, by modifying social 
capital, there could be a significant improvement in HIV treatment and management 
(Webel et al., 2012). Weidle et al. (2006) looked at adherence to ART, measured by 
sustained virological suppression, in a Ugandan home-based AIDS care programme. 
They found high rates of sustained virological suppression amongst patients enrolled in 
the home-care based programme and were able to demonstrate high level adherence to 
ART in these patients (Weidle et al., 2006). 
 
The study of Sivaram et al. (2009) in Chennai, India, examined the association between 
social capital and the social stigma of HIV/AIDS. Their results provided an insight into 
the association between social capital and HIV/AIDS. They found social capital 
indicators that were associated with reduction in fear amongst communities. This was 
particularly the case regarding the fear of transmission of HIV/AIDS from person to 
person (Sivaram et al., 2009). Another study by Frumence et al. (2014) in the Kagera 
Region of Tanzania examined access to social capital and the impact on reducing the 
risks of HIV infection. They examined the risk of HIV infection in Bukoka Urban 
District. Their findings revealed that individuals with high social capital were able to 
significantly reduce the risk of being infected by the HIV virus (described as high level of 
access to both cognitive and structural individual social capital) (Frumence et al., 2014).  
 
A number of other studies have examined various aspects of social capital and the 
association with HIV/AIDS, all with the intention of establising the contribution to 
reducing social stigma associated with having been infected with the virus. Sesane et al. 
(2014) examined the enhancement of social capital amongst communities in South Africa 
and found it to be very important in reducing social stigma associated with HIV/AIDS. 
Their findings were focused on the role of social workers in encouraging the 
enhancement of social capital and its contribution to reducing social stigma. Social 
workers were found to have a significant influence in promoting social change in 
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communities. They provided essential leadership and relationships considered critical for 
building families and communities’ capacities. Their contributions to sustainable, 
integrated social and economic development were judged to be remarkable. Finally, 
Sesane et al. (2014) found that social workers in South Africa played critical roles in 
combating HIV/AIDS related stigma through education and awareness (outreach 
programmes) which, in turn, help reduce the impact of social stigma on people living 
with HIV/AIDS. We can assumed from their findings that, by providing education and 
raising awareness through outreach programmes, there is a likelihood that these actions 
could create an environment for social cohesion and social participation from both the 
infected persons and uninfected persons.  The impact of social cohesion and social 
participation was discussed by Fonner et al. (2014). In their study, they found that higher 
levels of social cohesion and social participation were associated with protective 
behaviours during sexual intercourse. The use of condoms and HIV/AIDS testing were 
the key protective behaviours. However, these protective behaviours were also found to 
be inversely associated with HIV-related risk factors which included social 
discrimination and violence against people infected by the virus or living with the virus 
(Fonner et al., 2014). 
 
Although there are many definitions of social capital, for the purpose of this study, social 
capital was categorised into three broad groups. The categorisations are based on what 
Putnam et al. (1993) described as i) groups or networks, ii) trust and solidarity, and iii) 
collective actions and cooperation. Groups or networks are inclusive of religious groups 
and close friends but are not limited to these two. Trust and solidarity are encompassed 
by community support systems which include support from neighbours, friends and 
family members.  Collective actions and cooperation are experienced through community 
action, participation and support from neighbours. 
 
Groups and networks 
Studies looking at groups and networks and HIV risk, which are specific to people living 
with HIV/AIDS in sub-Sahara Africa, North Africa and Asia, have reported conflicting 
results. Pronyk et al. (2008b) showed a negative effect; Campbell et al. (2002) showed a 
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negative effect in older people but a positive effect in young people; while Gregson et al. 
(2011) reported a negative effect amongst men and a positive effect amongst women. 
Other studies that showed only positive effects included those in Uganda (Agardh et al., 
2010) and Zimbabwe (Gregson et al., 2011).  
 
  Trust and solidarity 
Several studies have addressed trust and solidarity as an aspect of social capital. Overall, 
there were positive outcomes associated with HIV. Agardh et al. (2010) provided useful 
insight into how trust and solidarity are key social capital elements. They looked at 
Mbarara University students in Uganda and found  that trust played a significant role in 
shaping sexual behaviour (Agardh et al., 2010). Campbell et al. (2002) also provided 
evidence of influences of trust and solidarity, through membership of community groups 
amongst the Carletonville community near Johannesburg in South Africa.  
 
Collective actions and cooperation 
Similarly, a few studies have addressed collective actions and cooperation, including one 
by Frumence et al. (2010) in Kagera Village in Tanzania, and another by Gregson et al. 
(2011) on women in Zimbabwe. Both studies provide useful insight about how 
populations with common interests can be moved to act collectively and to cooperate 
when faced with challenges.  
 
Various tools have been used to measure social capital. These tools include the interview-
administered questionnaires; self-administered questionnaires; focus groups, using a 
qualitative approach; and the measuring of responses using a priority ranking of low, 
medium and high social capital. There has been none that assigned a score to social 
capital (an actual number), as was done in this study.  
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1.4 Aim and objectives  
 
The aim of the study was to establish whether social capital is associated with HIV 
treatment outcomes, particularly ART adherence and virological failure, in HIV patients 
on ART at 12 months in South Africa.  
 
The study objectives were: 
1) To describe social capital in a group of HIV-positive patients on ART treatment at 
12 months. 
2) To determine the association of the demographic characteristics of these patients 
with social capital. 
3) To determine the association between social capital and virological failure at 12 
months among these patients. 
4) To determine the association between social capital and ART visit adherence at 
12 months among these patients. 
 
2  MATERIALS AND METHODS 
 
2.1 Study design 
 
This was a cross-sectional secondary data analysis of patients who were interviewed as 
part of a larger cohort study, to investigate how patient outcomes were linked to clinic 
characteristics. The objectives of the primary study were to identify clinic-level 
determinants of virological failure at a 12 & 24 month following start of ART among 
those with viral load results, controlling for individual determinants and to identify clinic-
level determinants of non-death losses in patients after starting ART, controlling for 
individual determinants. 
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2.2 Study setting 
 
From January 2006 to December 2010, a large cohort study was conducted by the Aurum 
Institute, at private and non-governmental organisation (NGO) clinics that it supports for 
ART implementation.   Patients were enrolled at 36 clinics (see Figure 1) which were part 
of the Aurum-managed programme funded by the President’s Emergency Plan for AIDS.  
The study was conducted to investigate how patient outcomes were linked to clinic 
characteristics. 
Figure 1. Distribution of study clinics (represented by diamonds) against a 
backdrop of antenatal prevalence by district (Source: Aurum Institute, 2009). 
 
2.3 Study population and sampling 
 
The study population of the primary study comprised adult HIV positive males and 
females, older than 18 years, attending the afore-mentioned clinics, who were on ART for 
more than one month. Patients identified by clinic staff as being suitable for inclusion in 
the study (n=943),  were interviewed as they exited from their first clinic visit, after 
giving written informed consent to participate in the primary study. Demographic 
characteristics, as well as issues regarding experiences of the service and patient-provider 
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interaction, were collected. Patients, who were unable to speak any of the languages that 
the interviewers were able to speak, were excluded from the primary study. 
 
Clinics were chosen if they had more than 80 patients that had initiated ART during the 
study period of 12 months, and were located in five provinces in South Africa, namely 
Gauteng, North West, Free State, Limpopo and Mpumalanga provinces. Of the clinics, 17 
were located in towns, 14 in cities and three in rural areas.  Twenty-five clinics were run 
by private solo practitioners, six were private group practices, and three were NGO 
clinics.  
 
 
2.4 Measurement 
 
It is important to emphasise that we were not able to identify a validated tool for 
measuring social capital. Questionnaires were collected to determine social capital as 
defined by group and network; trust and solidarity; and cooperation and collective action. 
The questionnaires included questions concerning each type of social capital as defined 
above and scores were assigned to responses. Responses to questions regarding HIV 
adherence and perceptions around HIV and health from  a previous study (Dahab et al., 
2008) were important determinants of adherence in this population.  These questions 
were obtained from a questionnaire previously used in this population. We also used 
questions to measure treatment literacy to understand HIV/AIDS and all aspects of ART, 
barriers to access and perceptions of the health service, also obtained from a 
questionnaire previously used in South Africa (Schneider et al., 2008).  
 
Routine data that were collected as part of the programme, from patients at each clinic 
visit after initiation of ART,  including demographic information and information related 
to adverse effects and changes in treatment ( recorded on the case report forms), were 
also included in the analysis reported here. The coding on the questionnaire of the 
primary study was the inverse to the coding used for the analysis of the secondary study 
(see Appendix 1 for questions used from the primary study).  
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2.4.1 Outcome and predictor variables 
 
Outcomes (dependent variables):  
 
The outcomes for the analysis reported here were visit non-adherence, unsuppressed viral 
load, and treatment failure.  Visit non-adherence was defined as fewer than five visits in 
the first year after start of ART. Visits following ART initiation were scheduled at 2 
weeks, 6 weeks, 3 months, 6 months, 9 months and 12 months (i.e. 7 visits in the first 
year, including the ART initiation visit).  Unsuppressed viral load was defined as HIV 
RNA viral load >400 copies/ml at 12 months after start of ART among those who had a 
viral load result. Treatment failure was defined as either no viral load result or viral load 
>400 copies/ml after 12 months. The three outcomes were dichotomised into 'adherence' 
and 'non adherence'; 'suppressed' and 'unsuppressed'; and 'yes' and 'no', respectively. 
 
Predictors (independent variables): 
 
Social capital was the main predictor variable (exposure variable) and was defined as low 
(score of <14), medium (score 15-22), or high (score 23-38). 
 
Potential confounders: 
Age (years) was categorised into three groups, viz. 'younger than 30', '30-40' and ‘older 
than 40'.  Gender was classified as male and female. Education level was categorised as 
'completed primary school', 'completed secondary school’ and 'undergraduate'. 
Occupation was categorised as 'employed' and 'unemployed'. Socio-economic status was 
assessed by type of residence (based on factors such as type of house, main material used 
for  walls,  roof, etc), wealth/income (number of rooms in the house, toilet facility, 
sources of water, sources of energy, ownership, eating habits, etc), and health (belonging 
to a medical aid, etc).  
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Socio-economic status scores ranged from 8 to 21. Individuals who had accumulated 
scores of 16-21, 10-15 and 8-9 were classified as belonging to low, middle and high 
socio-economic groups, respectively. Other variables such as marital status, migration, 
nationality, languages are shown in the tables in the Results section. 
 
 
Table 1. Scores allocated to responses to questions about social capital 
Social 
capital 
variable 
Question Coding on 
questionnaire of 
primary study 
Score given for 
analysis of secondary 
study 
Total 
possible 
score 
Section 
Total 
Groups and 
networks 
Are most of the 
members of these groups 
the same? 
 Yes No  Yes No 6  
Religion 1 0 Religion 0 1 
Gender 1 0 Gender 0 1 
Race 1 0 Race 0 1 
Ethnicity 1 0 Ethnicity 0 1 
Occupation 1 0 Occupation 0 1 
Education 1 0 Education 0 1 
How many close friends 
do you have these days 
and can feel at ease with 
when talking to them 
about private matter or 
calling on them for help? 
Number recorded as per 
response 
 
Number 
If >5 friends, then record 
5 
5 
 
 
 
How many such groups 
do you or members of 
household belong to and 
which of the group are 
most important to your 
household? 
Number recorded as per 
response 
 
Number  
If > 5 groups, then 
record 5  
5  
   16 
Trust and 
solidarity 
 
 
 
Generally speaking, 
would you say that most 
people can be trusted? 
Yes                            No   
 1                                0 
 
Yes                 N 
5                      0 
5  
What is the level of trust 
between the community 
and the following types 
of people or groups? 
1. Neighbours 
2. Strangers 
3. News Papers/TV 
4. National Leaders 
        5. Police 
No trust              =     1 
Low trust            =     2 
Medium trust      =     3 
High trust           =     4 
Complete trust    =     5 
 
 
 
No trust             =      1 
Low trust           =      2 
Medium trust     =      3 
High trust          =      4 
Complete trust  =       5 
5  
   30 
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2.5 Data analysis 
 
2.5.1 Data merging 
In this study, we linked the participant information with the social capital and outcome 
database. After merging, we looked at the HIV treatment outcomes of the participants’ 
outcomes from the start of treatment to 12 months after starting treatment.  
 
Collective 
action and 
cooperation 
 
If you suddenly needed 
to borrow a small 
amount of money, are 
there people beyond 
your immediate 
household and close 
relatives to whom you 
could turn to and they 
would be willing and 
able to provide this 
money? 
Definitely          = 1 
Probably = 2 
Unsure = 3 
Probably not = 4 
Definitely not = 5 
Definitely          =      5 
Probably            =     4 
Unsure               =     3 
Probably not      =     2 
Definitely not    =     1 
5 
If a community project 
does not directly benefit 
you but has benefits for 
many others in the 
village/neighbourhood, 
a) Would you contribute 
time to the project?  
b) Would you contribute 
money to the project?  
Yes = 1 
No = 0 
 
 
Yes=5 
 No=0 
 
5  
If you suddenly you had 
to go away for a day or 
two, who would take 
care of your children?  
 
Blood relative = 1 
Other relatives = 2 
A non-relative close 
friend = 3 
Neighbour = 4 
Work colleague = 5 
Member of a group you 
belong to  = 6 
No one = 7 
Blood relative = 2 
Other relatives = 2 
A non-relative close 
friend = 5 
Neighbour = 5 
Work colleague = 5 
Member of a group you 
belong to  = 5 
No one = 0 
5  
     15 
Total     61 
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2.5.2 Social capital 
Table 1 shows the questions that were asked in the questionnaire relating to each social 
capital variable, how the answers were scored, and the total possible score for each 
question. A study participant could have a high, medium or low level score in each of 
these three groups of social capital. For groups and networks, low social capital was 
defined by a score of <2, medium by a score of 3 – 7, and high by a score of 8 - 21. For 
trust and solidarity, low social capital was defined by a score of <1, medium by a score of 
2 – 6, and high by a score of was 7-10. For collective actions and cooperation, low social 
capital was defined by a score of <8, medium by a score of 9 - 12, and high by a score of 
13 - 15. Low overall social capital was defined by a score of <14, medium by a score of 
15 - 22, and high by a score of 23 - 38.  
 
2.5.3 Descriptive statistics 
Social capital was described by demographic factors, such as gender, age group, etc.  
Levels of social capital were grouped using the frequency centiles: for high, middle and 
low social capital, >75th, 25th to 75th and <25th centiles were used, respectively. The 
social capital factors measured were also used to determine to what extent a particular 
level of social capital influenced visit non-adherence, viral suppression and treatment 
failure.  
 
Categorical variables were summarised using frequencies and percentages, such as 
gender, age group, marital status, nationality, occupation, languages, education and socio-
economic status.  Continuous variables were summarised using means and standard 
deviations. ANOVA tests were used in determining differences in the means or medians 
of the groups. 
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2.5.4 Inferential statistics 
 
Odds ratios in a logistic regression model were calculated for categorical variables and, 
where a trend was evident, a chi-square test for trend was conducted. Variables that were 
noted to significantly confound the association with any of the three treatment outcomes 
were included in the final model.  
 
Univariable analyses were used to test for the associations between social capital and 
HIV treatment outcomes. A p-value of ≤0.2 was used for selection of variables to include 
in the multivariable model as confounders. The criteria used to identify a confounder 
were that the variable had to be associated with the exposure (social capital), but 
independently associated with one of the three HIV treatment outcomes; and that it 
should not be on a causal pathway. Moreover, in a stratified analysis, the stratum odd 
ratios (ORs) had to be similar, but different from the crude ORs. 
 
 
2.6 Ethical considerations 
 
Ethical clearance for the primary study was obtained from the Human Research Ethics 
Committee of the University of the Witwatersrand and the Ethics Committee of the 
London School of Hygiene and Tropical Medicine. Clearance for the secondary analysis 
of the data was obtained from the University of the Witwatersrand Human Research 
Ethics Committee (clearance certificate number M130240 - see Appendix 2). Permission 
to use the data was granted by the Aurum Institute after signing a confidentiality and non-
disclosure form. The Aurum Institute provided anonymous data for analysis.   
 
All information obtained during the course of the study was held securely. The data were 
analysed as individual data. No one outside of the study team had access to any of the 
information. 
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3 RESULTS 
 
3.1 Descriptive statistics 
 
3.1.1 Demographic characteristics 
 
A total of 1 324 HIV positive adults were included in the study, of whom 946 (71.5%) 
were female (Table 2); the average age was 40 years (SD±8.9). The majority of the study 
participants were South African (n=1 213; 91.6%), the most common language was Zulu 
(n=440; 33.2%), and most participants had a high school diploma (n=651; 49.1%).  
 
Although 56.9% (n=700) reported that they were unemployed, the majority of 
participants fell into the medium socio-economic status group (n=355; 62.6%).  
 
Table 2.  Demographic characteristics of study participants (N = 1 324) 
 
Factors Level N  % 
Gender Female 
Male 
946  
378  
71.5 
28.6 
Age(years) <30 
30-40 
>40 
176  
599  
549  
13.3 
45.2 
41.5 
Language Zulu 
Sesotho  
Tswana   
Sepedi 
Xhosa  
Other * 
440  
237      
231  
144   
  93 
179 
33.2 
17.9 
17.5 
10.9 
7.0 
13.5 
Nationality South African 
Other** 
1 213 
111  
91.6 
8.4 
Marital status Never married 
Married 
Widow/widower 
Living together 
Divorced 
613  
336  
144  
131  
100  
46.3 
25.4 
10.9 
9.9 
7.6 
Occupation Unemployed 
Employed 
700  
624  
56.9 
43.1 
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Living (with) Alone 
Partner 
1 071 
253 
80.9 
19.1 
Education Primary 
Secondary 
Undergraduate 
132 
651 
541 
9.9 
49.2 
40.9 
Migration SA Citizen 
Immigrant 
949 
375 
71.9 
28.3 
Socio-economic status*** Low 
Medium 
High 
32 
355 
180 
5.6 
62.6 
31.8 
 
*English, Afrikaans, Venda, Ndebele, SiSwati and Tsonga 
** Zimbabwean, Mozambican, Lesotho, Malawian, Botswana, Nigerian and Ghanaian 
***Measurements of SES were assessed by type of residence, wealth and income, etc. 
 
 
 
Figure 2. Number and proportions of participants in study at various stages 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
                     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
938 (99%) had adherence 
information 
759 (81%) were 
adherent (>5 visits) at 
12 months 
179 (19%) were non- 
adherent (<5 visits) at 
12 months 
381 missing social 
capital info 
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Figure 2 shows the number and proportions of participants in the study at various stages. 
Of the 1 324 patients interviewed, 943 (71.2%) had treatment outcome data available, 
759 (80.1%) had viral load results at 12 months, and 184 (13.8%) had missing viral load 
results. For the 759 (80.1%) viral load results, 641 (84.5%) were suppressed (<=400 
copies/ml) and 118 (15.6%) were unsuppressed (>400 copies/ml). There were data on 
adherence at 12 months available for most of the participants (n = 938; 99.9%): 759 
(80.9%) were adherent and 179 (19.1%) were non adherent.  
 
3.1.2 Social capital 
 
Social capital was measured in 943 of the study participants.  
 
Groups: When asked about whether the person or a member of his/her family was part of 
a group, The most important group to most people was member of their households (for 
86.2% of participants), and a member of their households were either part of one group; 
63 (10.1%) or part of two groups; 16 (2.6%) or part of three groups; and seven (1.1 %) 
were part of more than three groups. Of those belonging to a group, 240 (38.3%) had 
members who were the same gender, 128 (20.5%) came from the same religion, 118 
(19.2%) were of the same race, 199 (32.0%) were from the same ethnicity, 336 (53.9%) 
had the same occupation, and 334 (53.6%) had the same education.  Of all participants, 
130 (21.1%) had no friends, 475 (75.5%) had five or fewer friends, and 21 (3.4%) had 
more than five friends. 
 
Trust:  When asked if, generally, “most people can be trusted”, only 167 (26.7%) said 
yes.  Participants were asked about their opinion on the level of trust in the community 
and between different types of people or groups.  On a scale of 1 to 5, where 1 was no 
trust and 5 was complete trust, neighbours scored a median of 2 and strangers a median 
of 1, which implied low and complete lack of trust, respectively. Media, national leaders 
and police scored a median of 3 which indicated medium trust.  
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Cooperation: When asked if there were people who might be able to lend money to the 
participant, 477 (76.6%) said they would definitely or probably be able to borrow a small 
amount of money, 86 (13.6%) did not respond or were unsure, and 62 (9.7%) said they 
would probably not or definitely not be able to borrow a small amount of money.  Of all 
the respondents, 74.2% and 59.6%, respectively, agreed that they would contribute their 
time and money to projects that would not benefit them directly but were beneficial to the 
community as a whole. 
 
When asked who would take care of their children if  they had to suddenly go away for a 
day or two, 490 (78.1%) said relatives,  49 (7.9%) said non-relatives, and  87 (14.1%) 
said that there was no one who would do this.  
 
Baseline characteristics of patients according to social capital groups are reported in 
Table 3.  Being employed was found to be significantly associated with social capital 
(p=0.01).  Increasing age of the study participants was also associated with social capital 
(p=0.07), although this was not statistically significant. 
 
3.1.3 Confounders 
 
After investigating for confounders, using Mantel Haenszel Methods, it was established 
that none of the above predictors was a confounder for the relationship (association 
between treatment failure/ unsuppressed viral load and social capital). However, the 
association between visit non-adherence and social capital was confounded by 
employment. The final model was built by forward elimination.  
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Table 3. Baseline characteristics of patients according to different social  
capital group measures 
 
*P value for total social capital 
**Anova test 
***T-test  
 
Variable   
n 
Group and 
networks 
(mean) 
Trust and 
solidarity 
(mean) 
Cooperation 
and 
collective 
action 
(mean) 
Total 
Social 
capital 
(mean) 
P value* 
Age (years)      0.07** 
<30 68 4.40 3.59 9.63 17.62  
30 - 40 279 4.61 3.48 10.15 18.23  
>40 264 4.73 3.91 9.69 18.36  
Gender      0.23*** 
Female 465 4.68 3.67 10.02 18.38  
Male 146 4.51 3.72 9.47 17.70  
Marital status      0.31** 
Living together 46 5.28 4.78 9.89 19.96  
Married 155 4.73 3.79 10.21 18.73  
Divorced 47 4.57 4.17 10.15 18.89  
Never married 293 4.52 3.37 9.58 17.49  
Widow/Widower 70 4.54 3.64 10.36 18.54  
Nationality      0.47*** 
South African 598 4.64 3.67 9.88 18.20  
Other 13 4.54 3.84 10.54 18.92  
Occupation      0.01*** 
Employed 254 5.24 3.52 10.17 18.94  
Unemployed 357 4.21 3.79 9.69 17.71  
Language      0.59** 
Sepedi 110 5.58 3.00 10.01 18.59  
Tswana 111 5.09 3.16 9.54 17.80  
Zulu 149 4.62 4.33 10.12 19.07  
Others 73 4.41 4.30 9.92 18.61  
Xhosa 33 4.12 3.91 9.51 17.55  
Sesotho 135 3.76 3.55 9.92 17.27  
Education      0.72** 
Tertiary 258 5.08 3.43 10.19 18.70  
Secondary 283 4.35 3.85 9.76 17.98  
Primary 70 4.19 3.90 9.33 17.41  
Migration status      0.46*** 
Immigrant 113 5.00 3.55 9.29 18.30  
SA Citizen 498 4.56 3.71 10.03 17.84  
Socio-economic status      0.60** 
Medium 353 4.83 3.78 9.94 18.56  
High 179 4.67 3.47 10.04 18.19  
Low 32 4.53 4.16 10.19 18.88  
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3.2 Social capital factors affecting HIV treatment outcomes 
 
Table 4 shows the results of the analysis of the association of various factors with visit 
non-adherence.  In the univariable analysis, use of Tenofovir in the regimen was 
associated with visit non-adherence (0R=0.55; 95% CI=0.35-0.88). However, socio-
economic status, age, marital status, occupation, living single, gender, languages, 
education, migration, WHO stages, and NNRTIs regimen were not associated with visit 
non-adherence. 
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Table 4. Univariable and multivariable logistic regression analyses models for non-adherence (fewer than 5 visits) at 12 months 
(N=938) 
 
 Total Visit non-
adherence 
Univariable analysis Multivariable analysis 
Variable N  %   n % OR  95% CI P-Value OR  95% CI P-
Value 
Age (years)           
<30 100  11 20 20 1 (Ref)  - - - - 
30 - 40 412  44 78 19 0.93  0.54-1.62 0.80 - - - 
>40 426  45 81 19 0.94  0.54-1.62 0.82 - - - 
Gender           
Male 277  30 54  19 1 (Ref)  - - - - 
Female 661  70 125  19 0.96  0.67-1.37 0.84 - - - 
Marital status         -  
Married 241  26 43  18 1 (Ref)  - - - - 
Partner 97  10 11  11 0.59  0. 29-1.20 0.14 - - - 
Widow/widower 109  12 25  23 1.37  0.79-2.39 0.27 - - - 
Divorced 74  8 16  22 1.27  0.67- 2.41 0.47 - - - 
Single 417  44 84  20 1.16  0.77-1.75 0.47 - - - 
Nationality           
South African 869  93 163  19 1(Ref)  - - - - 
Other 69  7 16  9 1.31 0.73-2.35 0.37 - - - 
Living (with)         -  
Partner 757  81 146  19 1(Ref)  - - - - 
Alone 181 20 33  18 0.93  0.61-1.42 0.75 - - - 
Language           
Sesotho 171 18 32  19 1(Ref)  - - - - 
Xhosa 68 7 13  19 1.02  0.50- 2.10 0.94 - - - 
Sepedi 105 11 15  14 0.72  0.37-1.41 0.34 - - - 
Zulu 290 31 50  17 0.90  0.55- 1.47 0.69 - - - 
Tswana 176 19 38  22 1.19  0.71-2.02 0.51 - - - 
Others 128 14 31  24 1.39 0.79- 2.43 0.25 - - - 
Education       Pt*= 0.22    
Primary 93  10 17  18 1(Ref)  - - - - 
Secondary 461  49 99  21 1.22  0.69-2.16 0.49 - - - 
undergraduate 384  41 63  16 0.88 0.49-1.58 0.67 - - - 
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Migration status 
SA citizen 673  72 127  19 1(Ref)  - - - - 
Immigrant 265  28 52  20 1.04  0.73- 1.50 0.40 - - - 
Occupation           
Unemployed 529  56 98  19 1(Ref)  - - - - 
Employed 409  44 81  20 1.09 0.78- 1.50 0.62 - - - 
Socio-economic 
status 
          
High 130  32 25  19 1(Ref)  - - - - 
Medium 255  62 32  13 0.60  0.34-1.06 0.08 0.59 0.33- 1.06 0.08 
Low 23  6 0 0 -  - - - - 
WHO stages           
Stage 1 174  19 35  20 1(Ref)   - - - 
Stage 2 246  26 46  18 0.91 0.55-1.49 0.72 - - - 
Stage 3   336  36 52  15 0.72  0.45-1.17 0.19 - - - 
Stage 4 182  19 46  25 1.34  0.81-2.21 0.25 - - - 
NRTI regimen**           
Zidovudine(AZT) 103  11 29  28 1(Ref)  - 1.(Ref) - - 
Tenofovir 820  87 147  18 0.55  0.35-0.88 0.01 1.26 0.47-3.40 0.65 
Stavudine (D4T) 15  1.60 3  20 0.63 0.17-2.43 0.51 1.29 1.12-13.76 0.82 
NNRTI 
regimen*** 
          
Efavirenz 452  49 88  19 1(Ref)  - - - - 
Nevirapine 466  51 88  19 0.96  0.69-1.34 0.82 - - - 
Group and 
Network 
          
Low 143  33 25  17 1 (Ref)  - - - - 
Medium 208  47 29  14 0.78  0.44 – 1.40 - - - - 
High 91  21 9  10 0.53  0.24 – 1.19 - - - - 
Trust and 
Solidarity 
          
Low 109  24 181  17 1 (Ref)  - - - - 
Medium 239  54 33  14 0.81  0.43 – 1.51 - - - - 
High 97  22 12  12 0.71  0.32 – 1.57 - - - - 
Collective Action 
and Cooperation 
          
Low 119  27 21  18 1 (Ref)   - - - 
Medium 300  68 28  13 0.68  0.38 – 1.21  - - - 
High 25  6 4  16 0.68  0.28 – 2.86  - - - 
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*P trend    **Nucleoside reverse transcriptase inhibitors      ***Non-nucleoside reverse transcriptase inhibitors. 
 
  
Social Capital Pt*= 0.33 
Low 118  27 19  16 1(Ref)  - 1.(Ref) - - 
Medium 221  50 32  14 0.88  0.48- 1.64 0.69 0.92 0.47-1.82 0.81 
High 104  23 12  12 0.68  0.31-1.47 0.33 0.81 0.36-1.87 0.63 
CD4 baseline           
<200 934  100 179  19 - - - - - - 
200 4 0.43 0 0 - - - - - - 
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In the multivariable model, none of the variables was associated with visit non-
adherence. Social capital was also not associated with visit non-adherence in either the 
univariable or multivariable analysis.
 
 
Table 5 provides the results of the analysis of the associations with unsuppressed viral 
load (>400 copies/ml) at 12 months for all those who had a viral load result. In the 
univariable analysis, being older than 40 years (OR=0.49; 95% CI=0.26-0.91) and being 
employed (OR=0.57; 95% CI=0.38-0.86) were associated with lower risk of 
unsuppressed viral load. However, the following factors were associated with increased 
risk of having an unsuppressed viral load: being single (OR=1.80; 95% CI=1.07-3.03), 
speaking Tswana and other languages as home languages compared to Sesotho 
(OR=2.09; 95% CI=1.03-4.25 and OR=2.14; 95% CI=1.00-4.57, respectively), and use of 
a nevirapine in the regimen (OR=1.57; 95% CI=1.04-2.36).  
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Table 5. Univariable and Multivariable logistic regression analyses model for unsuppressed viral load (VL>400 copies at 12 
months) (N= 759) 
 
Variable Total   Unsuppressed 
viral load 
Univariable analysis Multivariable analysis 
N % n % OR  95% CI PValue OR  95% CI P Value 
Age       Pt*= 0.01   Pt*= 0.70 
<30 76 10 17 22 1 (Ref)  - 1 (Ref)  - 
30 - 40 333 44 58 17 0.73  0.40-1.35 0.32 1.07  0.34-3.34 0.91 
>40 350 46 43 12 0.49  0.26- 0.91 0.02 0.92  0.28- 3.04 0.90 
Gender           
Male 219 29 33 15 1 (Ref)  - -  - 
Female 540 72 85 16 1.05  0.68- 1.63 0.81 -  - 
Marital status           
Married 188 25 22 12 1 (Ref)  - 1 (Ref)  - 
Living together 78 10 12 16 1.37  0.64-2.93 0.41 1.89  0.57-6.28 0.30 
Widow/widower 97 13 12 12 1.07  0.50-2.26 0.87 0.49  0.14-1.69 0.26 
Divorced 59 8 8 14 1.02  0.41-2.51 0.97 1.18  0.35-3.95 0.78 
Single 337 44 64 19 1.80  1.07- 3.03 0.03 1.14  0.53- 2.48 0.73 
Nationality           
South African 703 93 112 16 1 (Ref)  - -  - 
Others 56 7 6 11 0 .63  0.27-1.51  0.30 -  - 
Living (with)           
Partner 143 19 103 11 1 (Ref)  - 1 (Ref)  - 
Alone 616 81 15 17 1.71 0.96- 3.05 0.07 0.53  0.57-6.28 0.23 
Language           
Sesotho 133 18 13 10 1 (Ref)  - 1 (Ref)  - 
Xhosa 52 7 8 17 1.93  0.77- 4.84 0.16 1.05  0.24- 4.53 0.95 
Sepedi 80 11 13 16 1.79  0.79-4.09 0.17 1.80  0.67-4.80 0.24 
Zulu 247 33 37 15 1.63  0.83-3.18 0.16 1.14  0.42-3.10 0.79 
Tswana 146 19 27 19 2.09  1.03-4.25 0.04 1.78  0.70-4.53 0.23 
Others 101 13 19 19 2.14  1.00-4.57 0.05 2.6  0.77-6.60 0.49 
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Education 
Primary 73 10 7 10 1 (Ref)  - 1 (Ref)  - 
Secondary 372 40 67 18 2.07  0.91-4.72 0.08 1.92  0.65-5.67 1.19 
undergraduate 314 41 44 14 1.54  0.66-3.57 0.32 0.92  0.29-2.98 0.89 
Migrant           
Citizen 537 71 36 16 1 (Ref)  - -  - 
immigrant 222 29 82 15 1.07  0.70-1.65 0.74 -  - 
Occupation           
Unemployed 408 54 82 19 1 (Ref)  - 1.(Ref)  - 
Employed 351 46 36 12 0.57  0.38- 0.86 0.01 0.60  0.31-1.14 0.12 
Socio-economic 
status 
          
High 97 29 17 18 1 (Ref)  - -  - 
Medium 215 65 36 17 1.05 0.55- 2.00 0.88 -  - 
Low 20 6 6 30 2.17 0.72- 6.49 0.17 -  - 
WHO stages       Pt*= 0.79    
Stage 1 151 20 25 17 1 (Ref)  - -  - 
Stage 2 187 27 29 16 0.92  0.52-1.66 0.79 -  - 
Stage 3   275 36 41 15 0.88  0.51- 1.52 0.65 -  - 
Stage 4 146 19 23 16 1.21  0.77- 1.90 0.41 -  - 
NRTI regimen**           
Zidovudine(AZT) 92 12 16 17 1 (Ref)   -  - 
 Tenofovir 655 86 100 15 0.85  0.48- 1.53 0.60 -  - 
Stavudine (D4T) 12 2 2.() 17 0.95  0.19-4.76 0.95 -  - 
NNRTI regimen**           
Efavirenz 367 49 46  1 (Ref)  - 1.(Ref)  - 
Nevirapine 375 51 69  18 1.57  1.04- 2.36 0.03 1.56  0.84-2.87 0.16 
Group and 
Network 
          
Low 109  30 22  20 1 (Ref)  - -  - 
Medium 170  47 26  15 071  0.38 – 1.34 - -  - 
High 80  22 13  16 0.77  0.36 – 1.63 - -  - 
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Trust and 
Solidarity 
Low 95 26 15  16 1 (Ref)  - -  - 
Medium 185  52 37  20 1.33  0.69 – 2.57 - -  - 
High 79  22 9  11 0.69  0.28 – 1.66 - -  - 
Collective Action 
and Cooperation 
          
Low 92  26 20  22 1 (Ref)  - -  - 
Medium 246  69 38  15 1.33  0.69 – 2.57 - -  - 
High 20  6 3  15   - -  - 
Social Capital           
Low 91  25 23  25 1 (Ref)  - 1 (Ref)  - 
Medium 180  50 25  14 0.47  0.25- 0.88 0.02 0.48  0.24-0.96 0.04 
High 87  24 13  15 0.51  0.24- 1.09 0.08 0.69  0.30-1.57 0.38 
CD4 baseline           
<200 756  100 118  16 1 (Ref)   -  - 
200 3  0 0  0 1   -  - 
*P trend
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Social capital was associated with lower risk of unsuppressed viral load in both the 
univariable and multivariable analysis. In the multivariable analysis, controlling for age, 
marital status, occupation, languages, living single, education and NNRTI, social capital 
was still associated with lower risk of unsuppressed viral load at 12 months (OR=0.48; 
95% CI=0.24-0.96).  There was a trend association between social capital and decreasing 
age (p=0.01). 
 
Table 6 shows the results of the analysis of the associations with treatment failure (either 
no virological result or unsuppressed viral load) at 12 months. In the univariable analysis, 
patients older than 40 years were less likely to have treatment failure (OR=0.57; 95% 
CI=0.36-0.89). However,  marital status, socio economic status, gender, migration status, 
WHO stage, NRTIs, CD4 count, education, occupation, living alone, language, and 
nationality were not statistically associated with treatment failure. Among the social 
capital variables, social capital composite was associated with a lower risk of treatment 
failure (OR=0.59; 95% CI=0.37- 0.97). In the multivariable model, after controlling for 
age, marital status, socio-economic status and NRTI regimen, social capital was still 
associated with a lower risk of treatment failure (OR=0.52; 95% CI=0.32-0.88). There 
was a trend towards an association of higher social capital with lower treatment failure 
(p-trend =0.05). 
 
Although social capital is a composite indicator/predictor, it has been shown to have 
characteristics that have the ability to hide certain disparities in terms of analysis. For 
instance, the results revealed that patients with medium trust and solidarity social capital 
are almost twice as likely (OR=1.68, 95% CI =1.02 – 2.74)   to experience treatment 
failure compared to patients with low trust and solidarity. In addition, patients with 
medium collective actions and cooperation have about 30% (OR = 0.69, 95% CI= 0.45 – 
1.087) reduced risk of experiencing treatment failure compared to patients with low 
collective actions and cooperation. Such information cannot be obtained by simple 
analyses using the composite indicator. 
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Table 6. Univariable and Multivariable logistic regression analyses model for treatment failure 
(VL>400 copies or no viral load) at 12 months. (N=942) 
 
Variables Total               Treatment               Univariable                       Multivariable 
                         Failure 
N             % n           %   OR         95% CI P Value OR         95% CI  P 
Value 
Age (years)      Pt*= 0.01  Pt*= 
0.58 
<30   100    11    41   41 1 (Ref) - 1 (Ref) - 
30 - 40   412   44  139   34 0.72         0.46-1.13 0.16 0.52     0.24- 1.14 0.11 
>40 430 46  121 28 0.57        0.36- 0.89 0.01 0.59     0.27- 1.31 0.20 
Gender         
Male   277    29    90  33 1 (Ref) - - - 
Female   665    71  211  32 0.94         0.70-1.27 0.70 - - 
Marital status         
Married   242    26    77   32 1 (Ref) - 1 (Ref) - 
Partner   101    11    34   34 1.11         0.68-1.82 0.68 0.95    0.42- 2.14  0.91 
Widow/widower   109    12    23   21 0.62         0.36-1.05 0.07 0.68    0.31- 1.47  0.33 
Divorced     73     8    22   30 1.00         0.57-1.77 0.99 0.98    0.42- 2.28  0.97 
Single   417    44  145  35 1.15         0.82-1.62 0.41 0 .78    0.46- 1.33 0.37 
Nationality         
South African   871   92  281  32 1 (Ref) - - - 
Others     71    8   20  29 0.82         0.48-1.41 0.48 - - 
Living (with)         
Partner  183  19    56   31 1 (Ref) - - - 
Alone  759  81  245   32 1.12        0.79-1.58 0.54 - - 
Language         
Sesotho  172  18   51  30 1 (Ref) - - - 
Xhosa    67   7   24   35 1.32        0.73-2.41 0.36 - - 
Sepedi  106  11    39  37 1.38         0.83-2.31 0.22 - - 
Zulu  291   31    82  28 0.93         0.61-1.41 0.74 - - 
Tswana  176   19    58  33 1.16        0.74- 1.84 0.51 - - 
Others   130 14  47 36 1.34        0.82- 2.18 0.23 - - 
Education         
Primary   94  10  26 28 1 (Ref) - - - 
Secondary   465  49  160 34 1.30         0.81-2.12 0.29 - - 
undergraduate   383  41  115 30 1.05         0.64-1.73 0.84 - - 
Migrant         
Citizen   675  72  82 31 1 (Ref) - - - 
immigrant   267  28  219 32 0.92         0.68-1.25 0.61 - - 
Occupation         
Unemployed   496 53  180 34 1 (Ref) - - - 
Employed   446 47  121 30 0.90        0.68- 1.18 0.44 - - 
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Socio-economic 
status 
High    131  32   50     38 1 (Ref) - 1 (Ref) - 
Medium    258  63   80     31 0.68        0.44- 1.05 0.09 0.67     0.43- 1.07 0.10 
Low      23    6     9    39 1.00         0.41-2.50 0.99 1.11     0.44- 2.82 0.82 
WHO stages         
Stage 1    176   19   50 28 1 (Ref) - - - 
Stage 2    247   26   89 36 1.42         0.93-2.16 0.10 - - 
Stage3      337   36  103 31 1.11        0.74-1.66 0.61 - - 
Stage 4    182   19    59 32 1.21        0.77-1.90 0.41 - - 
NRTI regimen**         
Zidovudine(AZT)    104  11    28    27 1 (Ref) - - - 
Tenofovir    823  87  268    33 1.31         0.83-2.07 0.25 - - 
Stavudine (D4T)       15   2      5    33 1.36         0.42-4.32 0.61 - - 
NNRTI 
regimen** 
        
Efavirenz   454  49  133  29 1 (Ref) - 1 (Ref) - 
Nevirapine   468  51  162  35 1.28         0.97-1.69 0.08 1.32    0 .86- 2.04 0.21 
Group and 
Network 
        
Low    146   33 59   40 1 (Ref) - - - 
Medium    210   47 66    31 0.68    0.44 – 1.05 - - - 
High     93   21 26    28 0.57    0.33 – 1.00 - - - 
Trust and 
Solidarity 
        
Low    110 25 30    27 1 (Ref) - - - 
Medium      24 54 93    39  1.68    1.02 – 2.74 - - - 
High      98 22 28    29 1.06    0.58 – 1.96 - - - 
Collective 
Action and 
Cooperation 
        
Low    119   27  47   40 1 (Ref) - - - 
Medium    303    68  95   31 0.69    0.45 – 1.08 - - - 
High      26 6   9    35 0.81    0.33 – 1.97 - - - 
Social Capital      Pt*= 0.05   
Low     118 26  51    43 1 (Ref) - 1 (Ref) - 
Medium     222 50   68    30 0.59         0.37-0.97 0.02 0 .52    0.32- 0.88 0.02 
High     108 24   32     45 0.62         0.36-1.08 0.09 0 .58    0.32- 1.05 0.07 
CD4 baseline         
<200     939 100 301    32 1 (Ref) - - - 
200        4  0     1     25 0.71        0.07- 6.82 0.76 - - 
*P trend
 
 
 
 
 
 
  
 
34 
 
Table 7 shows the results of the analysis of the summary of treatment outcomes by social 
capital groups. The mean score for group and network social capital was lower in patients 
with treatment failure compared to those with treatment success (P=0.01).  Although not 
statistically significant, mean scores for group and network social capital was lower in 
patients with unsuppressed viral load compared to those with suppressed viral load 
(P=0.63) and lower in patients with visit non-adherence compared to those with visit 
adherence (P=0.32). Mean scores for trust were not significantly different by outcomes.  
 
The mean score for collective action showed a trend for being lower in patients with visit 
non-adherence compared to those with visit adherence (P=0.08), although not statistically 
significant.  It was also lower in patients with unsuppressed viral load compared to those 
with suppressed viral load (P=0.06), and also in those with treatment failure compared to 
treatment success (P=0.06). 
 
 
Table 7. Summary of Treatment Outcomes by Social Capital Groups 
 
Treatment 
outcome 
Total Group and 
network
a
 
Trust and 
Solidarity
b 
Collective action 
and Cooperation
c 
Social Capital
d 
 N        % Mean P. value Mean P. value Mean P. value Mean P. value 
Suppressed 641     68 5.04 0.63 3.72 0.17 10.14 0.06 18.93 0.07 
Unsupressed 302     32 4.81 3.19 9.42 17.44 
Adherence 759     81 4.81 0.32 3.68 0.57 10.04 0.08 18.56 0.10 
Non-adherence 179     19 4.38 3.48 9.38 17.24 
Treatment 
success 
641     68 5.04 0.01 3.71 0.54 10.15 0.06 18.93 0.01 
Treatment 
failure 
302      32 4.23 3.54 9.62 17.41 
 
a. Measured by the number of organizations to which the respondent belongs, maximum score 16. 
b. Measured on the levels of trust generally (5) and then with different groups i.e. neighbours, strangers, newspapers, national 
leaders and police (25), maximum score 30. 
c. measured by asking questions about ability to borrow money (5), volunteering time (5), volunteering money (5) and having 
someone to take care of one's children (5), maximum score 15. 
d. Measured as the combination of group and network, trust and solidarity, collective action and cooperation (i.e. group-
network score+ trust-solidarity score+ collective action-cooperation score), maximum score 61. 
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Assessment of the logistic model 
 
3.3  Treatment Failure 
  
After comparing the final model that included social capital, age, employment and marital status 
(Model E) with the first model (Model A) that included only social capital, the chi-square result 
was 4.57 (P = 0.599). There is not enough evidence to reject the null hypothesis that Model E 
was an improvement of Model A.  We then used the Hosmer and Lemeshow goodness of fit test 
for the final model, and found that the Pearson chi-square test statistic was 49.47 with a P-value 
of 0.807. We did not reject the null hypothesis and therefore concluded that the fitted final model 
was reliable. 
 
Table 8. Model evaluation 
 
 
Covariate 
Visit Non-adherence Treatment Failure Unsupressed Viral Load 
AOR          95% CI AOR             95% CI AOR                 95% CI 
Social Capital    
Low 1 (Ref) 1 (Ref) 1 (Ref) 
Medium 0.93             0.47 – 1.84 0.56              0.35-0.88 0.49                     0.26-0.93 
High 0.82             0.36 – 1.86 0.59              0.34-1.03 0.58                     0.27-1.22 
Socio-economic Status    
High 1 (Ref)   
Meduim 0.61              0.34-1.08   
Low -   
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3.4 Unsuppressed Viral Load 
 
The final model with age, marital status, employment and social capital (Model F) compared to 
Model A that only included social capital. The chi-square test statistic was 4.18 (P = 0.759). In 
the Hosmer and Lemeshow goodness of fit for the final model, we found that the Pearson chi-
square test result was 36.77 (P= 0.982). We failed to reject the null hypothesis and therefore 
concluded that the final fitted model was reliable. 
 
 
3.5 Non-adherence 
 
The final model with social capital and socio-economic status (Model B) compared with the first 
Model (Model A) from the likelihood ratio test, however, shows that Model B (with social 
capital and socio-economic status) gave a marginal significant improvement over Model A: Chi
2
 
=2.74 (P= 0.097).  
 
 
4 DISCUSSION  
 
This is one of the few studies that have looked at social capital and HIV treatment 
outcomes in South Africa, and the only one that has used a method of scoring of social 
capital to show the effect of social capital on HIV/AIDS patients. Social capital benefits 
communities by encouraging togetherness and assists people suffering from chronic 
diseases to improve their wellbeing. Chronic diseases are accompanied by emotional and 
behavioural changes, depression and negatives feelings. Thomas and Thomas (1999) 
suggested that a community's social capital can be used as a tool to prevent HIV "by 
enhancing the skills of people in a community and providing them with opportunities and 
resources to care and advocate for one another" (Thomas and Thomas, 1999). Cattell 
(2001) and Kawachi et al. (1997) postulated that people with increased social capital cope 
better with stress and live longer than those with low social capital. In other words, low 
social capital is perceived as a factor for increased rate of morbidity.  
  
 
37 
 
In this study, people who were members of religious organisations or who benefited from 
employment, also enjoyed the extended benefits provided by these factors through social 
engagements. A typical example is workplace social capital which has been known to 
serve as a buffer. What this means is that people can rely on a friend at work to loan 
him/her money in the event of needing cash to cover some expenses.  
 
South Africa has one of the largest ART programmes in the world yet only a few studies 
on social capital and HIV treatment have been conducted. From general observations, I 
had suggested that South Africa does not have a well-structured social system compared 
to other African countries where people are more social. This argument can be supported 
by Seekings’ (2003) findings on how South African health statistics are published. For 
instance, they are published in racial categories, with little or no regard for the level of 
inequalities that exists amongst these racial groups. His research also shows that there is 
very little idea as to how class, however defined and measured, affects health. He pointed 
to the importance of class in South Africa from a perception that people did not   choose 
their class, when considering the country’s racial history (Seekings, 2003). His findings 
mirror several aspects of   South African society and the lack of a well-structured social 
system. Some of the key factors that have created these weak social systems are racial 
and economic inequalities.  
 
There are more social activities in other African countries compared to South Africa 
because the culture and ethnic groups of the populations in other countries have 
similarities. Social capital has also highlighted social inequalities which have been well-
documented in South Africa. Seekings’ research on class categories supports this claim 
(Seekings, 2003). Other research such as that by Wilkinson (1996) argued that 
socioeconomic inequality affects people’s health because it erodes social capital. A study 
by Campbell et al. (1999) on social capital and health suggested that social capital can act 
as a buffer against socioeconomic disadvantage by reducing the effect of a lack of 
economic resources. Thomas (1999) argued that social capital is necessary for a 
community to be healthy (Thomas and Thomas, 1999).  
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What we have seen from state interventions, are programme initiatives to reverse these 
negative trends. These initiatives include education and awareness in preventing the 
spread of HIV/AIDS, and ART. The implementation of social groups and networks can 
make a significant difference as we have seen in the case with people with cancer in the 
US overcoming their ailments (Sapp et al., 2003). Participation in social networks and 
groups created enabling environments to talk about their illnesses and get support. They 
had reasons to fight to survive and ensure their own well-being. These networks and 
groups encouraged them to continue with their therapy. Words of encouragement from 
their social engagements had positive outcomes and served to reinforce the benefits of 
social capital. We see the element of a growing self-esteem and confidence derived from 
people participating in groups. The example from the US by Sapp et al. (2003) provides 
evidence that social capital has produced clear benefits and has significantly contributed 
to the well-being of people with chronic diseases in communities.  
 
There are several well-documented reports on the benefits of social capital in 
communities with people struggling with chronic illness. This evidence is reflected in the 
work of Cattell (Cattell, 2001) and Runyan (Runyan et al., 1998). Social capital can assist 
HIV-infected persons to talk about their condition. By talking within networks or groups, 
people living with HIV can be assisted to overcome the social stigma associated with the 
ailment. They are encouraged to seek help through treatment and counselling.  
 
Miliband (2006) pointed to expressions of civic engagement within social networks that 
have created norms that tend to encourage people. These social engagements can be 
linked to acquaintances that provide assistance that help people gain employment and 
trust. The trust factor had usually influenced and encouraged people in groups to 
collaborate. There is also a certain amount of commitment on the part of people in groups 
to respect each other. They tend to adopt behavioural attitudes characterised by the 
willingness to share and take action when they see antisocial tendencies in their group or 
communities. From these social engagements, they are able to get advice on a host of 
health-related issues, including diets and physical activities. The outcomes from these 
social engagements have made a marked difference when comparing people living with 
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HIV/AIDS who have networks and groups that provide the platform to talk with those 
who do not have. People living with HIV who have no social engagements and no 
platform to talk normally withdraw into themselves and are often never better. They tend 
to become depressed and grow even sicker.  
 
Social capital can strengthen awareness amongst communities about the danger of 
HIV/AIDS. Measham and Brain (2005) were keen to stress that, in today’s social climate, 
it is normal to target resources that have, as their objective, the strengthening of social 
capital. In most modern societies today, commutators argue that traditional norms that 
include occupational stability, class-based communities and the family (seen as the 
nuclear of societies) are the foundation on which social capital has been nurtured. This 
has made social capital even more relevant in influencing positive health outcomes. 
Social capital has helped in educating communities by advocating life styles that, in turn, 
have reduced exposure and infection rates.  
 
In countries such as Uganda, Tanzania, etc., social capital has had a major influence on 
keeping HIV/AIDS patients on ART programmes (Mills et al., 2006). The outcomes from 
social engagements in these countries have encouraged patients to support each other 
through networks and group memberships. Social capital has also contributed to the 
decline in rates of infection. 
 
Social capital is a difficult concept to understand as it consists of different ways of 
measurement and has a   variety of definitions.  Several studies have identified useful 
proxy measurements for social capital using different types and combinations of 
qualitative, quantitative and comparative research methodologies. Webel et al. (2012) 
classified a mean social capital score higher than 2.5 as high social capital and anything 
less than 2.5 as low social capital. When compared to findings from our study, social 
capital was relatively high with a score of 17.41 to 18.93. The mean social capital score 
was greater than 2.5, although there is not a standard measure for social capital.  
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In this study, demographic factors associated with high social capital were older age and 
being employed. Because these people have built networks during their lives, they have 
families, children and friends, and are member of different networks and associations. 
These networks and associations include sport groups, leadership groups, etc. and would 
have increased their confidence given their age. Employed people are members of their 
workplaces where they have more chances to meet and interact with people. We also 
found that increased social capital was associated with lower risk of unsuppressed viral 
load and lower risk of treatment failure at 12 months in the univariable and multivariable 
analysis. However social capital was not associated with visit non- adherence. 
 
 
4.1 Social capital and unsuppressed viral load (>400 copies/ml) 
 
Older age (>40 years) and being employed were associated with lower risk of 
unsuppressed viral load at 12 months. After controlling for confounders, those in the 
medium and higher social capital groups were less likely to have an unsuppressed viral 
load compared to those in the low social capital group; however, the funding in high 
social capital group was not statistically significant.  
 
This study is the first to show that social capital is linked to a lower risk of having an 
unsuppressed viral load for those individuals on ART. Although it is known that social 
capital is likely to contribute to positive ART outcomes.   
 
Findings from this study provide evidence suggesting that people who are open about 
their ailments and who have the forum to talk about them have better outcomes. They 
developed self-esteem and confidence. This situation is similar to a study with cancer 
patients reported in the US (Sapp et al., 2003). By talking about their conditions, patients 
were able to overcome their ailments. A similar outcome can be seen in people who 
continue their therapy and improve their well-being. They derived encouragement from 
members in their networks and groups and advised on diet and physical exercise.  
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4.2 Social capital and treatment failure (missing viral load) 
 
Our study also revealed that patient’s low socio economic status, as well as being on an 
Nevirapine regimen, were associated with treatment failure. Social capital was found to 
be associated with treatment failure before and after controlling for confounders. 
Individuals with middle and higher social capital had a lower risk of treatment failure.  
 
 
4.3 Social capital and visit non-adherence 
 
Tenofovir regimen was found to be associated with visit non-adherence in this study 
population. We found that participants in the study group with low and middle socio- 
economic status were reportedly more likely to be non-adherent to ART, when compared 
to participants of high socio-economic status. This finding is considered true when we 
compare participants of  high-socio economic status with those of low and middle socio-
economic status regarding level of inequality in income because poor communities 
invariably suffer from poor health and these same communities also suffer from lack of 
employment opportunities and, therefore, income.  
 
Transportation attracts cost and places a significant burden on patients. Unemployed 
patients tend to travel very long distances to attend clinic sessions and they cannot afford 
to pay for their transportation.  
 
It is known that the lack of knowledge about HIV/AIDS and treatment programmes 
creates enormous amounts of fear. Social stigma caused by ignorance and the fear of 
being seen by other people may explain the non-adherence to ART. This is the same for 
knowledge deficit as a problem of non-disclosure that also leads to non-adherence to 
ART.  
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Tenofovir being associated with non-adherence could be due to side effects, such as 
nausea, asthenia, headache, renal insufficiency. Social capital was not associated with 
visit non-adherence by patients enrolled in the ART program in the univariable and 
multivariable analysis. 
 
 
4.4 Limitations 
 
The primary study from which these data were obtained had some limitations. The first 
was the timing of the interviews. Social capital was measured at one time point but 
outcomes were measured at 12 months after the start of ART. There was an assumption 
that the social capital measured at that time point remained constant while the person was 
on ART.  Nevertheless, the study design provided prospective data on a sample of 
patients that would not have been available in a cross-sectional study. 
 
The issue of HIV support groups or ‘treatment buddies’ was not addressed in the primary 
study. These have the potential of contributing substantially to social capital but this 
oversight could not be corrected in this secondary data analysis. 
 
Another limitation of the primary study is that it included only patients who were at the 
study clinic and available for interview. We are therefore likely to have overestimated 
treatment success due to selection bias. However, our study is not aimed at understanding 
treatment success but rather at understanding social capital and its effect on treatment 
success. Nevertheless, we could not measure social capital on those who had already left 
the programme.  
 
As we did not have validated tools for social capital, we used modified social capital 
scores. This made it difficult to compare the findings from this study with those from 
other studies.  
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These analyses assumed that all those with missing viral load results were treatment 
failures. We assumed that the reason for missing viral load results is that patients did not 
return for their viral load visits, but there may have been other reasons, such as problems 
with the laboratory and data management system.  
 
Finally, as this our study was not a clinical trial we did not have a control group to take 
care of all confounders. Nevertheless, we did adjust for those confounders that are 
commonly associated with the outcomes of interest.  Social capital, as a topic, does not 
lend itself to a clinical trial design.  
 
 
5 CONCLUSIONS AND RECOMMENDATIONS 
 
This study is the first to investigate the association between social capital and HIV 
outcomes in South Africa. The results are consistent with those from studies conducted 
elsewhere in the world but there remains much to learn, and using standardised and 
validated tools might improve the validity of futures studies. 
 
In view of the findings, we highlight some recommendations that included, but are not 
limited to, the following: 
 
We recommend that health care providers focus on younger age groups by promoting 
youth organisations and family support to reinforce social capital in the young 
population. In the case of unemployed people, where social capital is likely to be low, 
clinic staff should be made aware of this so that they can take steps to introduce measures 
that would encourage more social participation among unemployed patients. Social 
capital will not, itself, directly lead to job creation. However, it will help to ensure that 
communities in which unemployment rates are high do not struggle with additional 
difficulties related to lack of social capital. If we consider the clinic staff as agents that 
can encourages social participation and engagement in communities where 
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unemployment is high and social capital is low, their actions are very likely to create a 
more conducive environment for investment and job creation. 
 
There is a strong case for clinic staff to promote social capital and be aware of the 
importance of social capital; they can also include other measures to help patients with 
low social capital. 
While there is little evidence to suggest that these recommendations could hold true, they 
do leave room for further exploration of the association of social capital and HIV/AIDS 
treatment outcome.  
 
6 REFERENCES 
 
AGARDH, A., EMMELIN, M., MURIISA, R. & OSTERGREN, P. O. 2010. Social capital and 
sexual behavior among Ugandan university students. Glob Health Action, 3, 5432. DOI: 
10.3402/gha.v3i0.5432. 
 
CAMPBELL, C., WILLIAMS, B. & GILGEN, D. 2002. Is social capital a useful conceptual tool 
for exploring community level influences on HIV infection? An exploratory case study 
from South Africa. AIDS care, 14, 41-54. 
 
CARWEIN, V. L., SABO, C. E. & BERRY, D. E. 1993. HIV infection in traditional rural 
communities. The Nursing clinics of North America, 28, 231-239. 
 
CATTELL, V. 2001. Poor people, poor places, and poor health: the mediating role of social 
networks and social capital. Social science & medicine, 52, 1501-1516. 
 
CENE, C. W., AKERS, A. Y., LLOYD, S. W., ALBRITTON, T., POWELL HAMMOND, W. 
& CORBIE-SMITH, G. 2011. Understanding social capital and HIV risk in rural African 
American communities. J Gen Intern Med, 26, 737-44. 
 
CULLEN, M. & WHITEFORD, H. 2001. The interrelations of social capital with health and  
 mental health (discussion paper). Canberra: The Commonwealth of Australia  
 
DAHAB, M., CHARALAMBOUS, S., HAMILTON, R., FIELDING, K., KIELMANN, K., 
CHURCHYARD, G. J. & GRANT, A. D. 2008. That is why I stopped the ART": 
patients'& providers' perspectives on barriers to and enablers of HIV treatment adherence 
in a South African workplace programme. BMC Public Health, 8, 63. 
 
 
 
  
 
45 
 
DEPARTMENT OF HEALTH. 2010. Country Progress Report on the Declaration of 
Commitment on HIV/AIDS, 2010 Report. Pretoria: DOH. Available at:  
http://data.unaids.org/pub/report/2010/southafrica_2010_country_progress_report_en.pdf 
(accessed 12 Sep 2013). 
 
FONNER, V. A., KERRIGAN, D., MNISI, Z., KETENDE, S., KENNEDY, C. E. & BARAL, S. 
2014. Social cohesion, social participation, and HIV related risk among female sex 
workers in Swaziland. PLoS One, 9, e87527. 
 
FRUMENCE, G., EMMELIN, M., ERIKSSON, M., KWESIGABO, G., KILLEWO, J., MOYO, 
S. & NYSTRÖM, L. 2014. Access to social capital and risk of HIV infectionin Bukoba 
urban district, Kagera region, Tanzania. Archives of Public Health, 1-11. 
 
FRUMENCE, G., KILLEWO, J., KWESIGABO, G., NYSTROM, L., ERIKSSON, M. & 
EMMELIN, M. 2010. Social capital and the decline in HIV transmission - A case study 
in three villages in the Kagera region of Tanzania. SAHARA J, 7, 9-20. 
 
GREGSON, S., MUSHATI, P., GRUSIN, H., NHAMO, M., SCHUMACHER, C., SKOVDAL, 
M., NYAMUKAPA, C. & CAMPBELL, C. 2011. Social capital and women's reduced 
vulnerability to HIV infection in rural Zimbabwe. Popul Dev Rev, 37, 333-59. 
 
UNAIDS. 2012. Global report: UNAIDS report on the global AIDS epidemic. Available at: 
http://www.unaids.org/sites/default/files/media_asset/20121120_UNAIDS_Global_Repor
t_2012_with_annexes_en_1.pdf (accessed 29 Jun 2015). 
 
KAWACHI, I., KENNEDY, B. P., LOCHNER, K. & PROTHROW-STITH, D. 1997. Social 
capital, income inequality, and mortality. Am J Public Health, 87, 1491-8. 
 
MILLS, E. J., NACHEGA, J. B., BUCHAN, I., ORBINSKI, J., ATTARAN, A., SINGH, S., 
RACHLIS, B., WU, P., COOPER, C., THABANE, L., WILSON, K., GUYATT, G. H. & 
BANGSBERG, D. R. 2006. Adherence to antiretroviral therapy in sub-Saharan Africa 
and North America: a meta-analysis. JAMA, 296, 679-90. 
 
PRONYK, P. M., HARPHAM, T., BUSZA, J., PHETLA, G., MORISON, L. A., 
HARGREAVES, J. R., KIM, J. C., WATTS, C. H. & PORTER, J. D. 2008a. Can social 
capital be intentionally generated? a randomized trial from rural South Africa. Soc Sci 
Med, 67, 1559-70. 
 
PRONYK, P. M., HARPHAM, T., MORISON, L. A., HARGREAVES, J. R., KIM, J. C., 
PHETLA, G., WATTS, C. H. & PORTER, J. D. 2008b. Is social capital associated with 
HIV risk in rural South Africa? Soc Sci Med, 66, 1999-2010. 
 
REIMER, B. Understanding social capital: Its nature and manifestations in rural Canada.  CSAA 
Annual Conference, Toronto, Ontario, 2002. 
 
  
 
46 
 
RUNYAN, D. K., HUNTER, W. M., SOCOLAR, R. R., AMAYA-JACKSON, L., ENGLISH, 
D., LANDSVERK, J., DUBOWITZ, H., BROWNE, D. H., BANGDIWALA, S. I. & 
MATHEW, R. M. 1998. Children who prosper in unfavorable environments: the 
relationship to social capital. Pediatrics, 101, 12-18. 
 
SAPP, A. L., TRENTHAM‐DIETZ, A., NEWCOMB, P. A., HAMPTON, J. M., MOINPOUR, 
C. M. & REMINGTON, P. L. 2003. Social networks and quality of life among female 
long‐term colorectal cancer survivors. Cancer, 98, 1749-1758. 
 
SCHNEIDER, H., NAIDOO, N., NGOMA, B., GOUDGE, J., WILLIAMS, E., PURSELL, R., 
NYATELA, H. & LUBWAMA, J. 2008. Performance and capacity of second-generation 
Comprehensive Care Management and Treatment (CCMT) sites in Gauteng Province. 
South Africa. Centre for Health Policy, University of the Witwatersrand. Available at: 
http://www.healthlink.org.za/uploads/files/ccmtgp.pdf (accessed 26 Jun 2015). 
 
SEEKINGS, J. 2003. Social stratification and inequality in South Africa at the end of apartheid, 
Centre for Social Science Research, University of Cape Town. 
 
SIMBAYI, L., SHISANA, O., REHLE, T., ONOYA, D., JOOSTE, S., ZUNGU, N. & ZUMA, 
K. 2014. South African national HIV prevalence, incidence and behaviour survey, 2012. 
Pretoria: Human Sciences Research Council. 
 
SIVARAM, S., ZELAYA, C., SRIKRISHNAN, A., LATKIN, C., GO, V., SOLOMON, S. & 
CELENTANO, D. 2009. Associations between social capital and HIV stigma in Chennai, 
India: considerations for prevention intervention design. AIDS Education and Prevention, 
21, 233-250. 
 
SMITH, J. E., LANDAU, J. & BAHR, G. R. 1990. AIDS in rural and small town America: 
Making the heartland respond. AIDS Patient Care, 4, 17-21. 
 
THOMAS, J. C. & THOMAS, K. K. 1999. Things ain't what they ought to be: social forces 
underlying racial disparities in rates of sexually transmitted diseases in a rural North 
Carolina county. Social science & medicine, 49, 1075-1084. 
 
WARE, N. C., IDOKO, J., KAAYA, S., BIRARO, I. A., WYATT, M. A., AGBAJI, O., 
CHALAMILLA, G. & BANGSBERG, D. R. 2009. Explaining adherence success in sub-
Saharan Africa: an ethnographic study. PLoS Med, 6, e11. 
 
WEBEL, A., PHILLIPS, J. C., ROSE, C. D., HOLZEMER, W. L., CHEN, W. T., TYER-
VIOLA, L., RIVERO-MENDEZ, M., NICHOLAS, P., NOKES, K., KEMPPAINEN, J., 
SEFCIK, E., BRION, J., ELLER, L., IIPINGE, S., KIRKSEY, K., WANTLAND, D., 
CHAIPHIBALSARISDI, P., JOHNSON, M. O., PORTILLO, C., CORLESS, I. B., 
VOSS, J. & SALATA, R. A. 2012. A cross-sectional description of social capital in an 
international sample of persons living with HIV/AIDS (PLWH). BMC Public Health, 12, 
188. 
 
  
 
47 
 
WEIDLE, P. J., WAMAI, N., SOLBERG, P., LIECHTY, C., SENDAGALA, S., WERE, W., 
MERMIN, J., BUCHACZ, K., BEHUMBIIZE, P., RANSOM, R. L. & BUNNELL, R. 
2006. Adherence to antiretroviral therapy in a home-based AIDS care programme in rural 
Uganda. Lancet, 368, 1587-94. 
 
WOUTERS, E., MEULEMANS, H. & VAN RENSBURG, H. C. 2009. Slow to share: social 
capital and its role in public HIV disclosure among public sector ART patients in the Free 
State province of South Africa. AIDS care, 21, 411-21. 
 
 
  
  
 
48 
 
7 APPENDIXES 
 
Appendix 1:  Questions Pertaining to Social Capital 
   
 Questions relating to Social Capital, incorporated in questionnaire administered by 
AURUM for study to Determine Site-level Factors Which May Determine Clinical 
Outcomes on Antiretroviral Therapy (ART) in Patients Attending Primary Health Clinics 
in South Africa 
 “I would like to start by asking you about the groups or organizations, networks, 
associations to which you belong. These could be formally organized groups or just 
groups of people who get together regularly to do an activity or talk about things.  
Groups can be like a religious group mosque / church / shul / temple, savings club, burial 
society, political party, trade union, sport club, youth group, volunteer with police/fire 
brigade; residence association, women’s group, school committee, traders group, music 
group” 
 
Of how many such groups do you or members of household a member? .................. 
 Of all these groups to which you or members of your household belong, which one is the most 
important to you household? 
 
_______________________________________________________ [Name of group / type] 
 
 
Thinking about the members of this group, are most of them of the same 
RELIGION (1=Yes, 0=No)................................................................................................ 
GENDER (1=Yes, 0=No).................................................................................................. 
RACE (1=Yes, 0=No).......................................................................................................... 
ETHNIC/LINGUISTIC BACKGROUND (1=Yes, 0=No)........................................................ 
OCCUPATION (1=Yes, 0=No).......................................................................................... 
EDUCATION BACKGROUND/QUALIFICATIONS) (1=Yes, 0=No)....................................... 
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About how many close friends do you have these days? These are people you feel at ease with, 
can talk to about private matters, or call on for help…………............................ 
 
If you suddenly needed to borrow a small amount of money [RURAL: enough to pay for 
expenses for your household for one week; URBAN: equal to about one week’s wages], are 
there people beyond your immediate household and close relatives to whom you could turn to 
and would be willing and able to provide this money?.................................................. 
1= Definitely 
2= Probably 
3=Unsure 
4=Probably not 
5=Definitely not 
If you suddenly had to go away for a day or two, who would take care of your children? (give 
answers that apply) 
..……………………………………………..……………………………….… 
……………………………………………………………………………….… 
1= Blood relative (brother, sister, father, mother) 
2= Other relatives (e.g. in-laws)   
3= A non-relative close friend  
4= Neighbour 
5= Work colleague  
6= Member of a group you belong to   
7= No one 
Generally speaking, would you say that most people can be trusted (Yes=1, 
No=0?).................... 
If a community project does not directly benefit you but has benefits for many others in the 
village/neighbourhood, 
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 Would you contribute time to the project? (Yes=1, No=0?)............................................... 
Would you contribute money to the project? (Yes=1, No=0?)...................................................... 
 
What is the level of trust between in community and the following types of people or groups? 
                1=No trust  
                2=Low trust  
                3=Medium trust 
                4=High trust  
                5=Complete trust 
Neighbours.......................................................................................................................... 
Local leaders...................................................................................................................... 
Strangers............................................................................................................................ 
Newspaper/radio/TV........................................................................................................... 
Local government................................................................................................................ 
Provincial government.......................................................................................................... 
National government........................................................................................................... 
National leaders................................................................................................................... 
Police.................................................................................................................................... 
Security services …................................................................................................................ 
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